Margin clearance and outcome in resected pancreatic cancer. - Wikidata - awgldk - TriplyDB

Margin clearance and outcome in resected pancreatic cancer.

Margin clearance and outcome in resected pancreatic cancer.

http://www.wikidata.org/entity/Q39984329

about

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas EMT, CTCs and CSCs in tumor relapse and drug-resistance Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191 Diagnosis and management of pancreatic cancer.Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study Neoadjuvant therapy in pancreatic cancer: an emerging strategy TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma.Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.Management of pancreatic cancer: current status and future directions The prognostic and predictive value of serum CA19.9 in pancreatic cancer Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma Ductal adenocarcinoma of the pancreatic head: a focus on current diagnostic and surgical concepts Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy.An anatomical-based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment.Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?Definition of microscopic tumor clearance (r0) in pancreatic cancer resections.Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy.Resection margins in pancreatic cancer: are we entering a new era?Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Adjuvant chemotherapy in elderly patients with pancreatic cancer.Clinical and molecular characterization of HER2 amplified-pancreatic cancer.High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.Molecular pathology of pancreatic cancer: from bench-to-bedside translation.Resection margin involvement and tumour origin in pancreatic head cancer.Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.Resection margins in pancreatic cancer.

P2860

Q24595981-3C1ACDA4-8E27-4265-9E6E-92673E6DD52F Q26748880-3A3873CB-2A88-49D3-8562-607484518F56 Q28075892-A0C5F453-DDC4-4E22-92D9-2D10D6F916DB Q28082935-83DDFA2D-B624-47D9-A402-3CA621126AB0 Q33679644-62560D78-2426-4FFF-8D60-043723EFCA35 Q33755147-B0ED7E60-192F-4A02-9E5C-BEA3683A1C3F Q33759924-19E73C38-60BD-4F0C-ADF9-3057E6C5B209 Q33780907-EB426C22-68A9-4269-A8F3-C3E32F3BE3F4 Q33914671-EB09CB14-D03E-4B7A-AE25-E222CAAC0FE4 Q34324431-CB7F3A5B-D938-4A43-A79D-391F901CE8CC Q34331762-A53153F7-CE97-401E-AB02-2AA23C90439C Q34334926-72731026-995E-4487-8146-7DE4ED9F1518 Q34409883-5F7E8CAA-BFDE-48D5-BC66-0DBC235EEAF9 Q34635104-62ACF8D6-55A7-40D3-8197-3835D4DA951C Q34806852-1BE22C8E-FAD6-4CB3-B48C-40A3B1A360F8 Q35076334-983A08D2-CB26-48EF-AF4D-7D295EA131DF Q35504794-B1FDBFAB-CFFB-493A-B5BF-CD4838104591 Q35870404-6363F43C-93BF-4E0F-99F5-00A64BA09866 Q35925026-0E6FD9DE-EB01-46FF-94F8-4B6C61B9AD98 Q36066808-37067B1A-8453-43FB-AB5B-37E0FC0AB05F Q36113317-FCC519AD-EBA0-4C2F-9EE5-7AC46A219E1B Q36351984-547EF9AC-09F5-4875-AEB5-37F503A35E9C Q36609378-9424047D-46D8-40AA-BAA6-EE527F964B0B Q36666606-DC54200D-3252-42EA-9546-7DA82DE9C094 Q36668274-E82BECFE-C61B-43E5-B79D-0D44F85D1928 Q36773130-5E75EB6E-5A96-4F2F-BE6C-EAFE978ACCDC Q36871638-5421B656-E378-4539-B3C5-1311DB1F7B0A Q37342765-1DB7C2EF-806B-4620-A357-BB3B9C0EAA3A Q37389699-252AC499-7911-46D5-A54E-BF69AFB8EA7A Q37435242-752F8CA0-19E6-4837-AB90-343CD46BAA61 Q37467860-22EED501-83DE-424F-8940-1B858D3C85AF Q37480810-ED705567-74E8-4829-8C52-0B49B6C285FB Q37480826-C245E93E-5938-48E3-9F25-9440FD5268D5 Q37507381-8D20364B-3217-481B-A93D-33A36C4F0396 Q37690146-44B3E77E-98EB-435B-A5BD-27FCC6627F4F Q37944906-97535EB3-FCCF-4038-A117-C282B314EF7A Q37998096-D38216DF-DE02-439B-A44F-AA1551C28B18 Q38003878-6F37EE13-8881-4457-8EAC-EF5BF2ED6F90 Q38067446-231FA9C4-D278-42DB-94DF-A0BE9510D68E Q38160324-D8966A78-1BA0-43F5-8BD2-81107A1EAD48

P2860

Margin clearance and outcome in resected pancreatic cancer.

http://www.wikidata.org/entity/Q39984329

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Margin clearance and outcome in resected pancreatic cancer.

@en

Margin clearance and outcome in resected pancreatic cancer.

@nl

type

label

Margin clearance and outcome in resected pancreatic cancer.

@en

Margin clearance and outcome in resected pancreatic cancer.

@nl

prefLabel

Margin clearance and outcome in resected pancreatic cancer.

@en

Margin clearance and outcome in resected pancreatic cancer.

@nl

P1433

Q39984329-20F15D75-AB30-42FF-960D-49155CE86F15

P1476

Q39984329-F3E1BF98-5D4C-4BC4-A820-DB5F212FF4EC

P2093

Q39984329-079D413A-4703-4AE5-8E04-366675CA35AF

Q39984329-0DAC6FA2-8A28-4189-891C-5815F9810A26

Q39984329-23C08BE1-ABEB-4000-BB61-044D7BB5B583

Q39984329-69E85AEC-95AF-48E9-AD2F-1454228C3807

Q39984329-6DFA906C-E744-4268-A528-C2889D9484A9

Q39984329-9BEE3A1F-BAC0-47BE-BE83-DEBABEF79177

Q39984329-B75751C0-3DEF-4763-B9DD-D4DEBC4F7CB4

Q39984329-C5962C47-8B51-4959-AACE-1EA4C8BB85D1

Q39984329-EA5ED8F2-D0C9-497D-BA77-66EBF770126D

P304

Q39984329-67481E42-12FF-423F-8C6F-C3A1AF8EE125

P31

Q39984329-E106B178-0B53-405B-8275-FD6298AC5F56

P356

Q39984329-E80FE158-7F42-4393-84AB-0621EF074611

P407

Q39984329-43813786-F759-488A-B140-A00C081C55AD

P433

Q39984329-8E91EA7C-016E-4C6E-A530-9ADB31FA3AF7

P478

Q39984329-9FB252F6-C22B-45C8-983C-626210CD6DCC

P50

Q39984329-19B58CE0-31F5-46C6-8503-CED54F0B9C47

Q39984329-1E79C5D1-AA55-4BA3-A394-40BB0A442023

Q39984329-2294B483-D0AD-4D00-8CC2-1D6022EE680A

Q39984329-8A8AA926-559E-4F8C-8424-B3D9C055587A

Q39984329-EEE30AD6-FC3C-44F9-B886-9B9E06AA23C0

P577

Q39984329-6D52FD4D-3A17-4FAF-9C82-44D6919D1DBE

P698

Q39984329-BA50808C-4D74-4627-802D-E2C96F3E4D22

P356

JCO.2008.20.5104

P1433

Journal of Clinical Oncology

P1476

Margin clearance and outcome in resected pancreatic cancer.

@en

P2093

Amber L Johns

http://www.w3.org/2001/XMLSchema#string

Anthony J Gill

http://www.w3.org/2001/XMLSchema#string

Christopher J Scarlett

http://www.w3.org/2001/XMLSchema#string

Emily K Colvin

http://www.w3.org/2001/XMLSchema#string

Mark I Kelly

http://www.w3.org/2001/XMLSchema#string

Nam Q Nguyen

http://www.w3.org/2001/XMLSchema#string

Peter H Cosman

http://www.w3.org/2001/XMLSchema#string

Robert L Sutherland

http://www.w3.org/2001/XMLSchema#string

Susan M Henshall

http://www.w3.org/2001/XMLSchema#string

P304

2855-2862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.5104

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Neil D. Merrett

Rupert W. Leong

P577

2009-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19398572

http://www.w3.org/2001/XMLSchema#string